These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 23749333)

  • 1. Short-term effect of verapamil on coronary no-reflow associated with percutaneous coronary intervention in patients with acute coronary syndrome: a systematic review and meta-analysis of randomized controlled trials.
    Su Q; Li L; Liu Y
    Clin Cardiol; 2013 Aug; 36(8):E11-6. PubMed ID: 23749333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early administration of intracoronary verapamil improves myocardial perfusion during percutaneous coronary interventions for acute myocardial infarction.
    Hang CL; Wang CP; Yip HK; Yang CH; Guo GB; Wu CJ; Chen SM
    Chest; 2005 Oct; 128(4):2593-8. PubMed ID: 16236929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of short-term high-dose atorvastatin pretreatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a meta-analysis of nine randomized controlled trials.
    Liu Y; Su Q; Li L
    Clin Cardiol; 2013 Dec; 36(12):E41-8. PubMed ID: 24038054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-Term Effects of Verapamil and Diltiazem in the Treatment of No Reflow Phenomenon: A Meta-Analysis of Randomized Controlled Trials.
    Wang L; Cheng Z; Gu Y; Peng D
    Biomed Res Int; 2015; 2015():382086. PubMed ID: 26504804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intracoronary agents on the no-reflow phenomenon during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a network meta-analysis.
    Niu X; Zhang J; Bai M; Peng Y; Sun S; Zhang Z
    BMC Cardiovasc Disord; 2018 Jan; 18(1):3. PubMed ID: 29320987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarction.
    Su Q; Nyi TS; Li L
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD009503. PubMed ID: 25985145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dipyridamole versus verapamil for treatment of no-reflow during primary angioplasty.
    Tanzilli G; Greco C; Pasceri V; Pelliccia F; Arrivi A; Placanica A; Mangieri E
    Catheter Cardiovasc Interv; 2010 Nov; 76(6):787-93. PubMed ID: 20737584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarction.
    Aung Naing K; Li L; Su Q; Wu T
    Cochrane Database Syst Rev; 2013 Jun; (6):CD009503. PubMed ID: 23736949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intralesional versus intracoronary administration of glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention in patients with acute coronary syndromes: A meta-analysis of randomized controlled trials.
    Sun B; Liu Z; Yin H; Wang T; Chen T; Yang S; Jiang Z
    Medicine (Baltimore); 2017 Oct; 96(40):e8223. PubMed ID: 28984776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of nicorandil administration in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials.
    Geng N; Ren L; Xu L; Zou D; Pang W
    BMC Cardiovasc Disord; 2021 Oct; 21(1):488. PubMed ID: 34629058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiographic outcomes in the PLATO Trial (Platelet Inhibition and Patient Outcomes).
    Kunadian V; James SK; Wojdyla DM; Zorkun C; Wu J; Storey RF; Steg PG; Katus H; Emanuelsson H; Horrow J; Maya J; Wallentin L; Harrington RA; Gibson CM
    JACC Cardiovasc Interv; 2013 Jul; 6(7):671-83. PubMed ID: 23866179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Chinese Medicine on No or Slow Reflow after Percutaneous Coronary Intervention in Myocardial Infarction Patients: A Systematic Review and Meta-Analysis.
    Zhang XY; Sun Y; Yang XY; Hu JY; Zheng R; Chen SQ; Li M; Li CY; Jiang Y; Liu S; Zhao C; Xing YW; Shang HC
    Chin J Integr Med; 2020 Mar; 26(3):227-234. PubMed ID: 31093877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A
    Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Local Intracoronary Drug Delivery in Treatment of No-Reflow Phenomenon: A Pilot Study.
    Abu Arab T; Rafik R; El Etriby A
    J Interv Cardiol; 2016 Oct; 29(5):496-504. PubMed ID: 27465353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of intracoronary verapamil versus sodium nitroprusside for the prevention of microvascular obstruction during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Abdelaziz HK; Elkilany W; Khalid S; Sabet S; Saad M
    Coron Artery Dis; 2017 Jan; 28(1):11-16. PubMed ID: 27556348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Verapamil reverses myocardial no-reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction.
    Fu Q; Lu W; Huang YJ; Wu Q; Wang LG; Wang HB; Jiang SZ; Wang YJ
    Cell Biochem Biophys; 2013; 67(3):911-4. PubMed ID: 23559273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective, randomised, controlled trial to study the effect of intracoronary injection of verapamil and adenosine on coronary blood flow during percutaneous coronary intervention in patients with acute coronary syndromes.
    Vijayalakshmi K; Whittaker VJ; Kunadian B; Graham J; Wright RA; Hall JA; Sutton A; de Belder MA
    Heart; 2006 Sep; 92(9):1278-84. PubMed ID: 16449518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intracoronary nitroprusside injection on flow recovery during primary PCI in acute STEMI patients.
    Yang L; Mu L; Sun L; Qi F; Guo R
    Minerva Cardioangiol; 2017 Apr; 65(2):111-118. PubMed ID: 27249789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. REstoration of COronary flow in patients with no-reflow after primary coronary interVEntion of acute myocaRdial infarction (RECOVER).
    Huang D; Qian J; Ge L; Jin X; Jin H; Ma J; Liu Z; Zhang F; Dong L; Wang X; Yao K; Ge J
    Am Heart J; 2012 Sep; 164(3):394-401. PubMed ID: 22980307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of intracoronary pro-urokinase injection during percutaneous coronary intervention in treating ST elevation myocardial infarction patients: a systematic review and meta-analysis of randomized controlled trials.
    Yin XS; Huang YW; Li ZP; Dong JL; Zou JM; Tian L; Yang J
    Eur Rev Med Pharmacol Sci; 2022 Aug; 26(16):5802-5813. PubMed ID: 36066155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.